Personalized medicine, health care that targets medical interventions to patients based on their genetics, is currently being implemented in the health care delivery system, and the pace of implementation is expected to accelerate. However, while a significant amount of research is being focused on genomics – the mapping of genes to determine the origins and pathways of disease – there has been little research on the translation of genomics into clinical practice and health policy. This translation of research into policy and practice is critical to ensuring that the full potential of personalized medicine can be unleashed in the health care delivery system.
That is the mission of the Center for Translational and Policy Research on Personalized Medicine, the TRANSPERS Center. We are a first-of-its-kind research center for the study of personalized medicine and its translation into clinical care and health policy. We develop evidence-based information for patients, providers, industry, researchers and policymakers to objectively assess how new personalized medicine technologies can be used most beneficially and efficiently to improve health outcomes.
Kathryn Phillips, PhD
Principal Investigator, Center Founder and Director